nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—type 2 diabetes mellitus	0.788	1	CbGaD
Tyloxapol—LPL—brown adipose tissue—type 2 diabetes mellitus	0.0305	0.493	CbGeAlD
Tyloxapol—LPL—retina—type 2 diabetes mellitus	0.00552	0.0891	CbGeAlD
Tyloxapol—LPL—nephron tubule—type 2 diabetes mellitus	0.0052	0.084	CbGeAlD
Tyloxapol—LPL—cardiovascular system—type 2 diabetes mellitus	0.00467	0.0754	CbGeAlD
Tyloxapol—LPL—kidney—type 2 diabetes mellitus	0.00457	0.0738	CbGeAlD
Tyloxapol—LPL—cortex of kidney—type 2 diabetes mellitus	0.00445	0.0719	CbGeAlD
Tyloxapol—LPL—adipose tissue—type 2 diabetes mellitus	0.00412	0.0665	CbGeAlD
Tyloxapol—LPL—liver—type 2 diabetes mellitus	0.00289	0.0466	CbGeAlD
Tyloxapol—LPL—Disease—ENPP1—type 2 diabetes mellitus	0.000205	0.00137	CbGpPWpGaD
Tyloxapol—LPL—Disease—G6PC—type 2 diabetes mellitus	0.000205	0.00137	CbGpPWpGaD
Tyloxapol—LPL—Disease—PPP1R3C—type 2 diabetes mellitus	0.000205	0.00137	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000204	0.00136	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.000202	0.00135	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GPD2—type 2 diabetes mellitus	0.000202	0.00135	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CDO1—type 2 diabetes mellitus	0.000202	0.00135	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000198	0.00132	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.000197	0.00132	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.000196	0.00131	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AK1—type 2 diabetes mellitus	0.000193	0.00128	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.00019	0.00127	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—AKT1—type 2 diabetes mellitus	0.000188	0.00125	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000182	0.00121	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000178	0.00118	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MAT1A—type 2 diabetes mellitus	0.000178	0.00118	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.000177	0.00118	CbGpPWpGaD
Tyloxapol—LPL—Disease—ACACA—type 2 diabetes mellitus	0.000174	0.00116	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.000174	0.00116	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	0.000172	0.00115	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000172	0.00115	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—G6PC—type 2 diabetes mellitus	0.000172	0.00114	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HBA2—type 2 diabetes mellitus	0.000172	0.00114	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ND1—type 2 diabetes mellitus	0.000172	0.00114	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ENPP1—type 2 diabetes mellitus	0.000172	0.00114	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000172	0.00114	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GCGR—type 2 diabetes mellitus	0.000166	0.00111	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TGFB1—type 2 diabetes mellitus	0.000163	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000161	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC5A2—type 2 diabetes mellitus	0.000161	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.00016	0.00107	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYTB—type 2 diabetes mellitus	0.000157	0.00105	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—OXCT1—type 2 diabetes mellitus	0.000157	0.00105	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000153	0.00102	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TNF—type 2 diabetes mellitus	0.000152	0.00101	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000148	0.000987	CbGpPWpGaD
Tyloxapol—LPL—Disease—PCK1—type 2 diabetes mellitus	0.000146	0.000973	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ACACA—type 2 diabetes mellitus	0.000146	0.000973	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000146	0.000973	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—STAR—type 2 diabetes mellitus	0.000146	0.000973	CbGpPWpGaD
Tyloxapol—LPL—Disease—TLE4—type 2 diabetes mellitus	0.000142	0.000947	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CBS—type 2 diabetes mellitus	0.00014	0.000933	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCC8—type 2 diabetes mellitus	0.00014	0.000933	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000139	0.000927	CbGpPWpGaD
Tyloxapol—LPL—Disease—HK1—type 2 diabetes mellitus	0.000137	0.000911	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—COX2—type 2 diabetes mellitus	0.000135	0.000898	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000135	0.000898	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NCOA6—type 2 diabetes mellitus	0.000132	0.000882	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000132	0.000881	CbGpPWpGaD
Tyloxapol—LPL—Disease—GCKR—type 2 diabetes mellitus	0.000132	0.00088	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—UCP2—type 2 diabetes mellitus	0.00013	0.000867	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—UCP3—type 2 diabetes mellitus	0.00013	0.000867	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HSD11B1—type 2 diabetes mellitus	0.00013	0.000867	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CD36—type 2 diabetes mellitus	0.000128	0.000854	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000128	0.000853	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000128	0.000853	CbGpPWpGaD
Tyloxapol—LPL—Disease—ALDOB—type 2 diabetes mellitus	0.000127	0.000844	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000126	0.00084	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IL6—type 2 diabetes mellitus	0.000123	0.000818	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PCK1—type 2 diabetes mellitus	0.000122	0.000815	CbGpPWpGaD
Tyloxapol—LPL—Disease—SPRY2—type 2 diabetes mellitus	0.000121	0.000805	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000119	0.000794	CbGpPWpGaD
Tyloxapol—LPL—Disease—RBP4—type 2 diabetes mellitus	0.000118	0.000785	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000117	0.000783	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000117	0.00078	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HK1—type 2 diabetes mellitus	0.000114	0.000763	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000114	0.000763	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—LEP—type 2 diabetes mellitus	0.000113	0.000753	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000113	0.000751	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000111	0.000737	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000111	0.000737	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GCKR—type 2 diabetes mellitus	0.000111	0.000737	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LPA—type 2 diabetes mellitus	0.000111	0.000737	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC2A2—type 2 diabetes mellitus	0.00011	0.000733	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTR—type 2 diabetes mellitus	0.000108	0.000718	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000107	0.000713	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000106	0.000709	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALDOB—type 2 diabetes mellitus	0.000106	0.000707	CbGpPWpGaD
Tyloxapol—LPL—Disease—NAMPT—type 2 diabetes mellitus	0.000106	0.000704	CbGpPWpGaD
Tyloxapol—LPL—Disease—GCK—type 2 diabetes mellitus	0.000105	0.000699	CbGpPWpGaD
Tyloxapol—LPL—Disease—IAPP—type 2 diabetes mellitus	0.000104	0.000695	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000103	0.000687	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC9A1—type 2 diabetes mellitus	0.000102	0.000683	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000102	0.000682	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.000101	0.000673	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.97e-05	0.000665	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TLE4—type 2 diabetes mellitus	9.95e-05	0.000663	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GLP1R—type 2 diabetes mellitus	9.86e-05	0.000657	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARG—type 2 diabetes mellitus	9.84e-05	0.000656	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—INS—type 2 diabetes mellitus	9.65e-05	0.000643	CbGpPWpGaD
Tyloxapol—LPL—Disease—HMGA1—type 2 diabetes mellitus	9.59e-05	0.00064	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRB3—type 2 diabetes mellitus	9.57e-05	0.000638	CbGpPWpGaD
Tyloxapol—LPL—Disease—PSMD6—type 2 diabetes mellitus	9.41e-05	0.000627	CbGpPWpGaD
Tyloxapol—LPL—Disease—SNAP25—type 2 diabetes mellitus	9.41e-05	0.000627	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT2—type 2 diabetes mellitus	9.33e-05	0.000622	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CRHR1—type 2 diabetes mellitus	9.25e-05	0.000616	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC2A2—type 2 diabetes mellitus	9.2e-05	0.000613	CbGpPWpGaD
Tyloxapol—LPL—Disease—CYBA—type 2 diabetes mellitus	9.11e-05	0.000607	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CPT1A—type 2 diabetes mellitus	9.01e-05	0.000601	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTR—type 2 diabetes mellitus	9.01e-05	0.000601	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NAMPT—type 2 diabetes mellitus	8.84e-05	0.000589	CbGpPWpGaD
Tyloxapol—LPL—Disease—CALCA—type 2 diabetes mellitus	8.81e-05	0.000587	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.79e-05	0.000586	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LIPC—type 2 diabetes mellitus	8.78e-05	0.000586	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HBA1—type 2 diabetes mellitus	8.78e-05	0.000586	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GCK—type 2 diabetes mellitus	8.78e-05	0.000586	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP11A1—type 2 diabetes mellitus	8.73e-05	0.000582	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC9A1—type 2 diabetes mellitus	8.57e-05	0.000572	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	8.53e-05	0.000569	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC2A1—type 2 diabetes mellitus	8.51e-05	0.000567	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CETP—type 2 diabetes mellitus	8.48e-05	0.000565	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	8.46e-05	0.000564	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SPRY2—type 2 diabetes mellitus	8.46e-05	0.000564	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS1—type 2 diabetes mellitus	8.39e-05	0.000559	CbGpPWpGaD
Tyloxapol—LPL—Disease—TCF7L2—type 2 diabetes mellitus	8.3e-05	0.000553	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RBP4—type 2 diabetes mellitus	8.24e-05	0.000549	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GLP1R—type 2 diabetes mellitus	8.24e-05	0.000549	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC2A4—type 2 diabetes mellitus	8.16e-05	0.000544	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCKAR—type 2 diabetes mellitus	8.11e-05	0.000541	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RELA—type 2 diabetes mellitus	7.97e-05	0.000531	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.9e-05	0.000527	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PSMD6—type 2 diabetes mellitus	7.88e-05	0.000525	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SREBF1—type 2 diabetes mellitus	7.88e-05	0.000525	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SNAP25—type 2 diabetes mellitus	7.88e-05	0.000525	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CTGF—type 2 diabetes mellitus	7.73e-05	0.000516	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMGCR—type 2 diabetes mellitus	7.66e-05	0.000511	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.56e-05	0.000504	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ADRA2A—type 2 diabetes mellitus	7.5e-05	0.0005	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	7.35e-05	0.00049	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IAPP—type 2 diabetes mellitus	7.3e-05	0.000487	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—INSR—type 2 diabetes mellitus	7.26e-05	0.000484	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2E1—type 2 diabetes mellitus	7.21e-05	0.00048	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TRPC6—type 2 diabetes mellitus	7.13e-05	0.000475	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP1A2—type 2 diabetes mellitus	7.13e-05	0.000475	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC2A1—type 2 diabetes mellitus	7.13e-05	0.000475	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFBR2—type 2 diabetes mellitus	7.1e-05	0.000473	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGTR2—type 2 diabetes mellitus	7.09e-05	0.000472	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP3A4—type 2 diabetes mellitus	6.95e-05	0.000463	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.91e-05	0.000461	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN2B—type 2 diabetes mellitus	6.88e-05	0.000458	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GCG—type 2 diabetes mellitus	6.83e-05	0.000455	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC2A4—type 2 diabetes mellitus	6.83e-05	0.000455	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP9—type 2 diabetes mellitus	6.79e-05	0.000453	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.79e-05	0.000452	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NFKB1—type 2 diabetes mellitus	6.72e-05	0.000448	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOB—type 2 diabetes mellitus	6.7e-05	0.000447	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PSMD6—type 2 diabetes mellitus	6.59e-05	0.000439	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HTR2C—type 2 diabetes mellitus	6.59e-05	0.000439	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDNRA—type 2 diabetes mellitus	6.41e-05	0.000427	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CYBA—type 2 diabetes mellitus	6.38e-05	0.000425	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	6.27e-05	0.000418	CbGpPWpGaD
Tyloxapol—LPL—Disease—ADCY5—type 2 diabetes mellitus	6.27e-05	0.000418	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SRC—type 2 diabetes mellitus	6.26e-05	0.000417	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GHRL—type 2 diabetes mellitus	6.25e-05	0.000416	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PLAT—type 2 diabetes mellitus	6.25e-05	0.000416	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CALCA—type 2 diabetes mellitus	6.17e-05	0.000411	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—type 2 diabetes mellitus	6.1e-05	0.000407	CbGpPWpGaD
Tyloxapol—LPL—Disease—PPP2CA—type 2 diabetes mellitus	6.01e-05	0.0004	CbGpPWpGaD
Tyloxapol—LPL—Disease—CCR5—type 2 diabetes mellitus	5.9e-05	0.000393	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GNB3—type 2 diabetes mellitus	5.89e-05	0.000393	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.89e-05	0.000393	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMOX1—type 2 diabetes mellitus	5.86e-05	0.000391	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.81e-05	0.000387	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CAT—type 2 diabetes mellitus	5.78e-05	0.000386	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTHFR—type 2 diabetes mellitus	5.76e-05	0.000384	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GCG—type 2 diabetes mellitus	5.71e-05	0.000381	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.71e-05	0.000381	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.62e-05	0.000375	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOB—type 2 diabetes mellitus	5.61e-05	0.000374	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.6e-05	0.000373	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TGFB1—type 2 diabetes mellitus	5.6e-05	0.000373	CbGpPWpGaD
Tyloxapol—LPL—Disease—HIF1A—type 2 diabetes mellitus	5.5e-05	0.000366	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EGFR—type 2 diabetes mellitus	5.49e-05	0.000366	CbGpPWpGaD
Tyloxapol—LPL—Disease—IRS2—type 2 diabetes mellitus	5.48e-05	0.000366	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTM1—type 2 diabetes mellitus	5.46e-05	0.000364	CbGpPWpGaD
Tyloxapol—LPL—Disease—CALM1—type 2 diabetes mellitus	5.38e-05	0.000359	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOE—type 2 diabetes mellitus	5.37e-05	0.000358	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOA1—type 2 diabetes mellitus	5.3e-05	0.000354	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ADCY5—type 2 diabetes mellitus	5.25e-05	0.00035	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GPX1—type 2 diabetes mellitus	5.23e-05	0.000349	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—type 2 diabetes mellitus	5.23e-05	0.000348	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CD36—type 2 diabetes mellitus	5.09e-05	0.00034	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPP2CA—type 2 diabetes mellitus	5.03e-05	0.000335	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS2—type 2 diabetes mellitus	5e-05	0.000333	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.97e-05	0.000331	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.92e-05	0.000328	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.86e-05	0.000324	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AVP—type 2 diabetes mellitus	4.86e-05	0.000324	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.84e-05	0.000322	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTHFR—type 2 diabetes mellitus	4.83e-05	0.000322	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.81e-05	0.000321	CbGpPWpGaD
Tyloxapol—LPL—Disease—IRS1—type 2 diabetes mellitus	4.79e-05	0.000319	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARA—type 2 diabetes mellitus	4.74e-05	0.000316	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOB—type 2 diabetes mellitus	4.69e-05	0.000313	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.68e-05	0.000312	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.62e-05	0.000308	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AGT—type 2 diabetes mellitus	4.59e-05	0.000306	CbGpPWpGaD
Tyloxapol—LPL—Disease—INS—type 2 diabetes mellitus	4.58e-05	0.000306	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CALM1—type 2 diabetes mellitus	4.51e-05	0.000301	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOE—type 2 diabetes mellitus	4.49e-05	0.0003	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOA1—type 2 diabetes mellitus	4.44e-05	0.000296	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT2—type 2 diabetes mellitus	4.43e-05	0.000295	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.39e-05	0.000293	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6—type 2 diabetes mellitus	4.22e-05	0.000281	CbGpPWpGaD
Tyloxapol—LPL—Disease—SERPINE1—type 2 diabetes mellitus	4.21e-05	0.000281	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.21e-05	0.00028	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.13e-05	0.000275	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—C3—type 2 diabetes mellitus	4.04e-05	0.000269	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3R1—type 2 diabetes mellitus	4.02e-05	0.000268	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS3—type 2 diabetes mellitus	4.02e-05	0.000268	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARG—type 2 diabetes mellitus	3.91e-05	0.000261	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT1—type 2 diabetes mellitus	3.89e-05	0.000259	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.85e-05	0.000257	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.84e-05	0.000256	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—INS—type 2 diabetes mellitus	3.84e-05	0.000256	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGT—type 2 diabetes mellitus	3.83e-05	0.000256	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.77e-05	0.000251	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LEP—type 2 diabetes mellitus	3.76e-05	0.000251	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOE—type 2 diabetes mellitus	3.76e-05	0.000251	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.71e-05	0.000248	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—type 2 diabetes mellitus	3.68e-05	0.000245	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.54e-05	0.000236	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALB—type 2 diabetes mellitus	3.52e-05	0.000235	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NOS3—type 2 diabetes mellitus	3.37e-05	0.000224	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3R1—type 2 diabetes mellitus	3.37e-05	0.000224	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.35e-05	0.000223	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—INS—type 2 diabetes mellitus	3.21e-05	0.000214	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.16e-05	0.000211	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.1e-05	0.000207	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.1e-05	0.000207	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—type 2 diabetes mellitus	3.08e-05	0.000205	CbGpPWpGaD
Tyloxapol—LPL—Disease—SRC—type 2 diabetes mellitus	2.97e-05	0.000198	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.95e-05	0.000197	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.81e-05	0.000188	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.81e-05	0.000188	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFB1—type 2 diabetes mellitus	2.66e-05	0.000177	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RELA—type 2 diabetes mellitus	2.65e-05	0.000177	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGFR—type 2 diabetes mellitus	2.61e-05	0.000174	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.39e-05	0.000159	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.26e-05	0.000151	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.23e-05	0.000149	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SRC—type 2 diabetes mellitus	2.08e-05	0.000139	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.03e-05	0.000135	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6—type 2 diabetes mellitus	2e-05	0.000134	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.86e-05	0.000124	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT1—type 2 diabetes mellitus	1.85e-05	0.000123	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.83e-05	0.000122	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKT1—type 2 diabetes mellitus	1.55e-05	0.000103	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6—type 2 diabetes mellitus	1.4e-05	9.35e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.29e-05	8.63e-05	CbGpPWpGaD
